Early administration of probiotic Lactobacillus acidophilus and/or prebiotic inulin attenuates pathogen-mediated

Ondulla T Foye1, I-Fei Huang, Christine C Chiou

  • 1Mucosal Immunology Laboratory, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA.

Insights

Probiotics and prebiotics reduce gut inflammation in infant mice infected with Citrobacter rodentium. These interventions enhance host immunity by modulating NF-κB and Smad 7 signaling pathways.

Area of Science:

  • Immunology
  • Microbiology
  • Gastroenterology

Background:

  • Gut-associated immunity immaturity is a key factor in pediatric mortality from enteric infections.
  • Enteric pathogens like Citrobacter rodentium pose significant risks to infant health.
  • Understanding host-pathogen interactions is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To investigate the impact of Lactobacillus acidophilus (probiotic), inulin (prebiotic), and synbiotics on pathogen-induced inflammation in a pediatric enteric disease model.
  • To determine the effects of these interventions on NF-κB and Smad 7 signaling pathways.
  • To assess the modulation of host immune responses against Citrobacter rodentium infection.

Main Methods:

  • A murine model of infantile enteric disease was utilized.
  • Newborn mice were administered Lactobacillus acidophilus, inulin, or synbiotics bi-weekly for four weeks.
  • Mice were subsequently challenged with Citrobacter rodentium, and intestinal inflammation, bacterial colonization, and signaling pathways (NF-κB, Smad 7, IL-10, TGF-β) were analyzed.

Main Results:

  • Probiotic, prebiotic, and synbiotic treatments significantly reduced intestinal inflammation and bacterial colonization post-Citrobacter rodentium challenge.
  • Synbiotic treatment enhanced colonic IL-10 and transforming growth factor-β expression and inhibited NF-κB signaling.
  • All interventions (synbiotic, probiotic, prebiotic) attenuated Citrobacter rodentium-induced Smad 7 expression.

Conclusions:

  • Lactobacillus acidophilus, inulin, and synbiotics show potential in promoting host-protective immunity against enteric infections in infants.
  • These interventions may attenuate Citrobacter rodentium-induced intestinal inflammation by modulating NF-κB and Smad 7 signaling.
  • The findings support the use of probiotics and prebiotics for managing pediatric enteric diseases.

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...